Source: Pancreas. Conference titles: Minutes of the Business Meeting of the American Pancreatic Association. Unidade: FM
Subjects: NEOPLASIAS PANCREÁTICAS (HISTOPATOLOGIA), METÁSTASE NEOPLÁSICA, MODELOS ANIMAIS, RESUMOS (EVENTOS)
ABNT
MORIOKA, C. Y. et al. Is Farnesyltransferase Inhibitor Effective in Hamster Experimental Pancreatic Cancer Model As Neoadjuvant and Adjuvant Treatment?. Pancreas. New York: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://journals.lww.com/pancreasjournal/Fulltext/2004/11000/K_Ras_Point_Mutation_Detection_By_Pcr_Rflp.150.aspx. Acesso em: 03 nov. 2024. , 2004APA
Morioka, C. Y., Machado, M. C. C., Saito, S., Ohzawa, K., Matheus, A. S., Godoy, R. S., et al. (2004). Is Farnesyltransferase Inhibitor Effective in Hamster Experimental Pancreatic Cancer Model As Neoadjuvant and Adjuvant Treatment? Pancreas. New York: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://journals.lww.com/pancreasjournal/Fulltext/2004/11000/K_Ras_Point_Mutation_Detection_By_Pcr_Rflp.150.aspxNLM
Morioka CY, Machado MCC, Saito S, Ohzawa K, Matheus AS, Godoy RS, Jukemura J, Kubrusly MS, Bacchella T, Arai H, Sakamoto T, Watanabe A. Is Farnesyltransferase Inhibitor Effective in Hamster Experimental Pancreatic Cancer Model As Neoadjuvant and Adjuvant Treatment? [Internet]. Pancreas. 2004 ; 29( 4): 366.[citado 2024 nov. 03 ] Available from: http://journals.lww.com/pancreasjournal/Fulltext/2004/11000/K_Ras_Point_Mutation_Detection_By_Pcr_Rflp.150.aspxVancouver
Morioka CY, Machado MCC, Saito S, Ohzawa K, Matheus AS, Godoy RS, Jukemura J, Kubrusly MS, Bacchella T, Arai H, Sakamoto T, Watanabe A. Is Farnesyltransferase Inhibitor Effective in Hamster Experimental Pancreatic Cancer Model As Neoadjuvant and Adjuvant Treatment? [Internet]. Pancreas. 2004 ; 29( 4): 366.[citado 2024 nov. 03 ] Available from: http://journals.lww.com/pancreasjournal/Fulltext/2004/11000/K_Ras_Point_Mutation_Detection_By_Pcr_Rflp.150.aspx